Down-Regulation of TNF-Alpha by Small Interfering RNA Inhibits Particle-Induced Inflammation In Vitro

Aseptic joint loosening is a key factor that reduces the life span of arthroplasty. There are currently few effective treatments for joint loosening except surgical revision. We explored the inhibitory effects of tumor necrosis factor (TNF)‐alpha‐targeted small interfering RNA (siRNA) on particle‐in...

Full description

Saved in:
Bibliographic Details
Published inArtificial organs Vol. 35; no. 7; pp. 706 - 714
Main Authors Qin, Chu-qiang, Ding, Yue, Huang, Dong-sheng, Xu, Jie, Ma, Ruo-fan, Huang, Jian-bin
Format Journal Article
LanguageEnglish
Published Malden, USA Blackwell Publishing Inc 01.07.2011
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Aseptic joint loosening is a key factor that reduces the life span of arthroplasty. There are currently few effective treatments for joint loosening except surgical revision. We explored the inhibitory effects of tumor necrosis factor (TNF)‐alpha‐targeted small interfering RNA (siRNA) on particle‐induced inflammatory cytokine expression in the murine macrophage cell line, RAW264.7. siRNA targeting TNF‐alpha was chemically synthesized and transfected into RAW264.7 cells by cationic liposomes. Ceramic, titanium, and polyethylene particles of different sizes (0.2–1.2 µm and 1.2–10 µm) were prepared to stimulate cells 24 h after siRNA transfection. The down‐regulation of TNF‐alpha mRNA and protein levels was quantitatively determined using real‐time polymerase chain reaction (PCR) and enzyme‐linked immunosorbent assay (ELISA), respectively, at different time intervals. Fluorescence microscopy showed that the siRNA transfection efficiency was 85.2% ± 3.5%. Real‐time PCR showed that the levels of TNF‐alpha mRNA in the particle stimulation plus RNA interference (RNAi) groups were significantly lower compared with the particle stimulation‐only groups 3 h after stimulation (P < 0.05). Similarly, ELISA essays showed that the protein levels of TNF‐alpha in the RNAi‐treated groups were significantly decreased 24 h after transfection (P < 0.05). There were no significant differences in the inhibitory effect among the groups stimulated by different particle types or particle sizes (P > 0.05). Our results indicated that siRNA targeting TNF‐alpha can inhibit TNF‐alpha release from RAW264.7 cells when stimulated by ceramic, titanium, and polyethylene particles of different sizes and that the inhibitory effects were not related to the type or size of particle.
AbstractList Abstract Aseptic joint loosening is a key factor that reduces the life span of arthroplasty. There are currently few effective treatments for joint loosening except surgical revision. We explored the inhibitory effects of tumor necrosis factor (TNF)‐alpha‐targeted small interfering RNA (siRNA) on particle‐induced inflammatory cytokine expression in the murine macrophage cell line, RAW264.7. siRNA targeting TNF‐alpha was chemically synthesized and transfected into RAW264.7 cells by cationic liposomes. Ceramic, titanium, and polyethylene particles of different sizes (0.2–1.2 µm and 1.2–10 µm) were prepared to stimulate cells 24 h after siRNA transfection. The down‐regulation of TNF‐alpha mRNA and protein levels was quantitatively determined using real‐time polymerase chain reaction (PCR) and enzyme‐linked immunosorbent assay (ELISA), respectively, at different time intervals. Fluorescence microscopy showed that the siRNA transfection efficiency was 85.2% ± 3.5%. Real‐time PCR showed that the levels of TNF‐alpha mRNA in the particle stimulation plus RNA interference (RNAi) groups were significantly lower compared with the particle stimulation‐only groups 3 h after stimulation ( P  < 0.05). Similarly, ELISA essays showed that the protein levels of TNF‐alpha in the RNAi‐treated groups were significantly decreased 24 h after transfection ( P  < 0.05). There were no significant differences in the inhibitory effect among the groups stimulated by different particle types or particle sizes ( P  > 0.05). Our results indicated that siRNA targeting TNF‐alpha can inhibit TNF‐alpha release from RAW264.7 cells when stimulated by ceramic, titanium, and polyethylene particles of different sizes and that the inhibitory effects were not related to the type or size of particle.
Aseptic joint loosening is a key factor that reduces the life span of arthroplasty. There are currently few effective treatments for joint loosening except surgical revision. We explored the inhibitory effects of tumor necrosis factor (TNF)-alpha-targeted small interfering RNA (siRNA) on particle-induced inflammatory cytokine expression in the murine macrophage cell line, RAW264.7. siRNA targeting TNF-alpha was chemically synthesized and transfected into RAW264.7 cells by cationic liposomes. Ceramic, titanium, and polyethylene particles of different sizes (0.2-1.2 mu m and 1.2-10 mu m) were prepared to stimulate cells 24h after siRNA transfection. The down-regulation of TNF-alpha mRNA and protein levels was quantitatively determined using real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA), respectively, at different time intervals. Fluorescence microscopy showed that the siRNA transfection efficiency was 85.2%+/-3.5%. Real-time PCR showed that the levels of TNF-alpha mRNA in the particle stimulation plus RNA interference (RNAi) groups were significantly lower compared with the particle stimulation-only groups 3h after stimulation (P<0.05). Similarly, ELISA essays showed that the protein levels of TNF-alpha in the RNAi-treated groups were significantly decreased 24h after transfection (P<0.05). There were no significant differences in the inhibitory effect among the groups stimulated by different particle types or particle sizes (P>0.05). Our results indicated that siRNA targeting TNF-alpha can inhibit TNF-alpha release from RAW264.7 cells when stimulated by ceramic, titanium, and polyethylene particles of different sizes and that the inhibitory effects were not related to the type or size of particle.
Aseptic joint loosening is a key factor that reduces the life span of arthroplasty. There are currently few effective treatments for joint loosening except surgical revision. We explored the inhibitory effects of tumor necrosis factor (TNF)-alpha-targeted small interfering RNA (siRNA) on particle-induced inflammatory cytokine expression in the murine macrophage cell line, RAW264.7. siRNA targeting TNF-alpha was chemically synthesized and transfected into RAW264.7 cells by cationic liposomes. Ceramic, titanium, and polyethylene particles of different sizes (0.2-1.2 µm and 1.2-10 µm) were prepared to stimulate cells 24 h after siRNA transfection. The down-regulation of TNF-alpha mRNA and protein levels was quantitatively determined using real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA), respectively, at different time intervals. Fluorescence microscopy showed that the siRNA transfection efficiency was 85.2% ± 3.5%. Real-time PCR showed that the levels of TNF-alpha mRNA in the particle stimulation plus RNA interference (RNAi) groups were significantly lower compared with the particle stimulation-only groups 3 h after stimulation (P < 0.05). Similarly, ELISA essays showed that the protein levels of TNF-alpha in the RNAi-treated groups were significantly decreased 24 h after transfection (P < 0.05). There were no significant differences in the inhibitory effect among the groups stimulated by different particle types or particle sizes (P > 0.05). Our results indicated that siRNA targeting TNF-alpha can inhibit TNF-alpha release from RAW264.7 cells when stimulated by ceramic, titanium, and polyethylene particles of different sizes and that the inhibitory effects were not related to the type or size of particle.
Aseptic joint loosening is a key factor that reduces the life span of arthroplasty. There are currently few effective treatments for joint loosening except surgical revision. We explored the inhibitory effects of tumor necrosis factor (TNF)-alpha-targeted small interfering RNA (siRNA) on particle-induced inflammatory cytokine expression in the murine macrophage cell line, RAW264.7. siRNA targeting TNF-alpha was chemically synthesized and transfected into RAW264.7 cells by cationic liposomes. Ceramic, titanium, and polyethylene particles of different sizes (0.2-1.2 µm and 1.2-10 µm) were prepared to stimulate cells 24 h after siRNA transfection. The down-regulation of TNF-alpha mRNA and protein levels was quantitatively determined using real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA), respectively, at different time intervals. Fluorescence microscopy showed that the siRNA transfection efficiency was 85.2% ± 3.5%. Real-time PCR showed that the levels of TNF-alpha mRNA in the particle stimulation plus RNA interference (RNAi) groups were significantly lower compared with the particle stimulation-only groups 3 h after stimulation (P &lt; 0.05). Similarly, ELISA essays showed that the protein levels of TNF-alpha in the RNAi-treated groups were significantly decreased 24 h after transfection (P &lt; 0.05). There were no significant differences in the inhibitory effect among the groups stimulated by different particle types or particle sizes (P &gt; 0.05). Our results indicated that siRNA targeting TNF-alpha can inhibit TNF-alpha release from RAW264.7 cells when stimulated by ceramic, titanium, and polyethylene particles of different sizes and that the inhibitory effects were not related to the type or size of particle.
Author Huang, Jian-bin
Ding, Yue
Xu, Jie
Ma, Ruo-fan
Huang, Dong-sheng
Qin, Chu-qiang
Author_xml – sequence: 1
  givenname: Chu-qiang
  surname: Qin
  fullname: Qin, Chu-qiang
  organization: Department of Orthopaedic Surgery, The Second Affiliated Hospital of SUN YAT-SEN University, Guangzhou, China
– sequence: 2
  givenname: Yue
  surname: Ding
  fullname: Ding, Yue
  organization: Department of Orthopaedic Surgery, The Second Affiliated Hospital of SUN YAT-SEN University, Guangzhou, China
– sequence: 3
  givenname: Dong-sheng
  surname: Huang
  fullname: Huang, Dong-sheng
  organization: Department of Orthopaedic Surgery, The Second Affiliated Hospital of SUN YAT-SEN University, Guangzhou, China
– sequence: 4
  givenname: Jie
  surname: Xu
  fullname: Xu, Jie
  organization: Department of Orthopaedic Surgery, The Second Affiliated Hospital of SUN YAT-SEN University, Guangzhou, China
– sequence: 5
  givenname: Ruo-fan
  surname: Ma
  fullname: Ma, Ruo-fan
  organization: Department of Orthopaedic Surgery, The Second Affiliated Hospital of SUN YAT-SEN University, Guangzhou, China
– sequence: 6
  givenname: Jian-bin
  surname: Huang
  fullname: Huang, Jian-bin
  organization: Department of Orthopaedic Surgery, The Second Affiliated Hospital of SUN YAT-SEN University, Guangzhou, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21501190$$D View this record in MEDLINE/PubMed
BookMark eNqNkV1P2zAYha2JaRS2vzDlblfp7CT-yMUuWhhdESpTgW3ajWUnb8Cdk3R2Itp_j7NAb4dv_PGe51g65wQdNW0DCEUET0lYnzdTQhMaE5pn0wSHV0wIp9PdGzQ5DI7QBBOGY8qyX8foxPsNxphnmL1DxwmhgcjxBMF5-9jEa7jvrepM20RtFd2uLuKZ3T6oSO-jm1pZGy2bDlwFzjT30Xo1C_cHo03no-_KdaawEC-bsi-gDJPKqroezZZN9MN0rn2P3lbKevjwvJ-iu4uvt2ff4qvrxfJsdhUXFAsaK51gSHjOSqx5yjWlJAOogNFSF1rorEpSwpVIAZckFxXRTLGUsjQDUYJg6Sn6NPpuXfu3B9_J2vgCrFUNtL2XQgicU5bT_ys54yLlPA1KMSoL13rvoJJbZ2rl9pJgObQhN3IIXQ6hy6EN-a8NuQvox-dPel1DeQBf4g-CL6Pg0VjYv9pYzq7Xwynw8cgb38HuwCv3R7IQIJU_VwuZLxbz35fztZynT-ABqHs
CitedBy_id crossref_primary_10_1111_j_1525_1594_2012_01568_x
crossref_primary_10_1039_D0BM00147C
crossref_primary_10_5301_ijao_5000218
crossref_primary_10_1002_cbin_11544
crossref_primary_10_1111_aor_13271
crossref_primary_10_1038_s41420_022_00999_2
crossref_primary_10_1111_j_1525_1594_2012_01438_x
crossref_primary_10_1002_jbm_a_35912
crossref_primary_10_1021_acsbiomaterials_2c01509
crossref_primary_10_1007_s10753_013_9636_9
crossref_primary_10_1016_j_jddst_2019_05_008
crossref_primary_10_1002_jbm_a_36983
crossref_primary_10_1038_s41598_018_38456_9
crossref_primary_10_1002_jcp_29978
crossref_primary_10_3892_ijmm_2013_1392
crossref_primary_10_1089_jir_2020_0090
Cites_doi 10.1261/rna5160904
10.1097/00003086-200212000-00019
10.1016/j.berh.2006.06.002
10.1016/j.bone.2006.12.053
10.1016/S0002-9440(10)63016-7
10.1038/sj.gt.3302192
10.4049/jimmunol.180.6.4292
10.4049/jimmunol.169.10.5754
10.1001/jama.295.19.2275
10.1038/sj.gt.3300596
10.1016/j.biomaterials.2008.12.018
10.1016/j.biomaterials.2006.04.004
10.1016/j.pharmthera.2007.08.004
10.2106/JBJS.G.00130
10.1111/j.1525-1594.2009.00736.x
10.1038/35888
10.1016/S0736-0266(01)00088-2
10.2302/kjm.54.127
10.1097/01.blo.0000142288.66246.4d
10.1302/0301-620X.82B7.10762
10.1038/nrd1175
10.1002/jbm.b.30120
ContentType Journal Article
Copyright 2011, Copyright the Authors. Artificial Organs © 2011, International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.
Copyright_xml – notice: 2011, Copyright the Authors. Artificial Organs © 2011, International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7QO
7TM
8FD
FR3
P64
DOI 10.1111/j.1525-1594.2010.01175.x
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
Biotechnology Research Abstracts
Nucleic Acids Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Nucleic Acids Abstracts
Biotechnology and BioEngineering Abstracts
DatabaseTitleList CrossRef
Engineering Research Database
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1525-1594
EndPage 714
ExternalDocumentID 10_1111_j_1525_1594_2010_01175_x
21501190
AOR1175
ark_67375_WNG_9GGBZJBR_B
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
23N
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6P2
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHEFC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EST
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HKTDT
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
ZGI
ZXP
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7QO
7TM
8FD
FR3
P64
ID FETCH-LOGICAL-c5085-ab20e2796d0b737b5514eefe65dbcb8b4f2317a83e0d198f1b6a635634e8de863
IEDL.DBID DR2
ISSN 0160-564X
IngestDate Fri Aug 16 10:12:22 EDT 2024
Fri Aug 16 20:38:25 EDT 2024
Fri Aug 23 03:34:29 EDT 2024
Sat Sep 28 07:59:32 EDT 2024
Sat Aug 24 00:52:34 EDT 2024
Wed Oct 30 09:55:06 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
License 2011, Copyright the Authors. Artificial Organs © 2011, International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5085-ab20e2796d0b737b5514eefe65dbcb8b4f2317a83e0d198f1b6a635634e8de863
Notes ark:/67375/WNG-9GGBZJBR-B
istex:58342C91174D6E9F59768CE9301259FA9BFC2014
ArticleID:AOR1175
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
PMID 21501190
PQID 876783773
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_888095695
proquest_miscellaneous_876783773
crossref_primary_10_1111_j_1525_1594_2010_01175_x
pubmed_primary_21501190
wiley_primary_10_1111_j_1525_1594_2010_01175_x_AOR1175
istex_primary_ark_67375_WNG_9GGBZJBR_B
PublicationCentury 2000
PublicationDate July 2011
PublicationDateYYYYMMDD 2011-07-01
PublicationDate_xml – month: 07
  year: 2011
  text: July 2011
PublicationDecade 2010
PublicationPlace Malden, USA
PublicationPlace_xml – name: Malden, USA
– name: United States
PublicationTitle Artificial organs
PublicationTitleAlternate Artif Organs
PublicationYear 2011
Publisher Blackwell Publishing Inc
Publisher_xml – name: Blackwell Publishing Inc
References Chamekh M, Phalipon A, Quertainmont R, Salmon I, Sansonetti P, Allaoui A. Delivery of biologically active anti-inflammatory cytokines IL-10 and IL-1ra in vivo by the Shigella type III secretion apparatus. J Immunol 2008;180:4292-8.
Yang SY, Wu B, Mayton L, et al. Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysis. Gene Ther 2004;11:483-91.
Yang M, Mattes J. Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs. Pharmacol Ther 2008;117:94-104.
McManus MT, Haines BB, Dillon CP, et al. Small interfering RNA-mediated gene silencing in T lymphocytes. J Immunol 2002;169:5754-60.
Boyce BF, Li P, Yao Z, et al. TNF-alpha and pathologic bone resorption. Keio J Med 2005;54:127-31.
Taki N, Tatro JM, Lowe R, Goldberg VM, Greenfield EM. Comparison of the roles of IL-1, IL-6, and TNFalpha in cell culture and murine models of aseptic loosening. Bone 2007;40:1276-83.
Warme BA, Epstein NJ, Trindade MC, et al. Proinflammatory mediator expression in a novel murine model of titanium-particle-induced intramedullary inflammation. J Biomed Mater Res B Appl Biomater 2004;71:360-6.
Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006;295:2275-85.
Clohisy JC, Teitelbaum S, Chen S, Erdmann JM, Abu-Amer Y. Tumor necrosis factor-alpha mediates polymethylmethacrylate particle-induced NF-kappaB activation in osteoclast precursor cells. J Orthop Res 2002;20:174-81.
Bierbaum BE, Nairus J, Kuesis D, Morrison JC, Ward D. Ceramic-on-ceramic bearings in total hip arthroplasty. Clin Orthop Relat Res 2002;405:158-63.
Yang JP, Huang L. Time-dependent maturation of cationic liposome-DNA complex for serum resistance. Gene Ther 1998;5:380-7.
Nam KW, Yoo JJ, Lae KY, Kim YM, Lee MH, Kim HJ. Alumina-debris-induced osteolysis in contemporary alumina-on-alumina total hip arthroplasty. A case report. J Bone Joint Surg Am 2007;89:2499-503.
Xu JW, Konttinen YT, Lassus J, et al. Tumor necrosis factor-alpha (TNF-alpha) in loosening of total hip replacement (THR). Clin Exp Rheumatol 1996;14:643-8.
Liu F, Zhu Z, Mao Y, Liu M, Tang T, Qiu S. Inhibition of titanium particle-induced osteoclastogenesis through inactivation of NFATc1 by VIVIT peptide. Biomaterials 2009;30:1756-62.
Fender D, Harper WM, Gregg PJ. The Trent regional arthroplasty study. Experiences with a hip register. J Bone Joint Surg Br 2000;82:944-7.
Saleh KJ, Thongtrangan I, Schwarz EM. Osteolysis: medical and surgical approaches. Clin Orthop Relat Res 2004;427:138-47.
Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391:806-11.
Desai SB, Furst DE. Problems encountered during anti-tumour necrosis factor therapy. Best Pract Res Clin Rheumatol 2006;20:757-90.
Palladino MA, Bahjat FR, Theodorakis EA, Moldawer LL. Anti-TNF-alpha therapies: the next generation. Nat Rev Drug Discov 2003;2:736-46.
Pettit AR, Ji H, von Stechow D, et al. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 2001;159:1689-99.
Persengiev SP, Zhu X, Green MR. Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). Rna 2004;10:12-18.
Ren WP, Markel DC, Zhang R, et al. Association between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivo. Biomaterials 2006;27:5161-9.
Beraudi A, Stea S, Cremonini S, Visentin M, Toni A. Assessment of five interleukins in human synovial fluid as possible markers for aseptic loosening of hip arthroplasty. Artif Organs 2009;33:538-43.
2004; 10
2004; 11
2009; 33
2008; 180
1998; 391
2009; 30
2006; 20
2004; 71
2002; 20
2006; 27
2002; 169
2003; 2
2006; 295
2000; 82
2005; 54
2008; 117
2002; 405
2007; 40
1996; 14
2004; 427
1998; 5
2007; 89
2001; 159
e_1_2_8_16_2
e_1_2_8_17_2
e_1_2_8_18_2
e_1_2_8_19_2
Nam KW (e_1_2_8_3_2) 2007; 89
e_1_2_8_12_2
e_1_2_8_23_2
e_1_2_8_13_2
e_1_2_8_24_2
e_1_2_8_14_2
e_1_2_8_15_2
e_1_2_8_9_2
Xu JW (e_1_2_8_8_2) 1996; 14
e_1_2_8_2_2
e_1_2_8_4_2
e_1_2_8_6_2
e_1_2_8_5_2
e_1_2_8_7_2
e_1_2_8_20_2
e_1_2_8_10_2
e_1_2_8_21_2
e_1_2_8_11_2
e_1_2_8_22_2
References_xml – volume: 14
  start-page: 643
  year: 1996
  end-page: 8
  article-title: Tumor necrosis factor‐alpha (TNF‐alpha) in loosening of total hip replacement (THR)
  publication-title: Clin Exp Rheumatol
– volume: 33
  start-page: 538
  year: 2009
  end-page: 43
  article-title: Assessment of five interleukins in human synovial fluid as possible markers for aseptic loosening of hip arthroplasty
  publication-title: Artif Organs
– volume: 10
  start-page: 12
  year: 2004
  end-page: 18
  article-title: Nonspecific, concentration‐dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs)
  publication-title: Rna
– volume: 71
  start-page: 360
  year: 2004
  end-page: 6
  article-title: Proinflammatory mediator expression in a novel murine model of titanium‐particle‐induced intramedullary inflammation
  publication-title: J Biomed Mater Res B Appl Biomater
– volume: 180
  start-page: 4292
  year: 2008
  end-page: 8
  article-title: Delivery of biologically active anti‐inflammatory cytokines IL‐10 and IL‐1ra in vivo by the Shigella type III secretion apparatus
  publication-title: J Immunol
– volume: 11
  start-page: 483
  year: 2004
  end-page: 91
  article-title: Protective effects of IL‐1Ra or vIL‐10 gene transfer on a murine model of wear debris‐induced osteolysis
  publication-title: Gene Ther
– volume: 27
  start-page: 5161
  year: 2006
  end-page: 9
  article-title: Association between UHMWPE particle‐induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt‐1 in vivo
  publication-title: Biomaterials
– volume: 159
  start-page: 1689
  year: 2001
  end-page: 99
  article-title: TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis
  publication-title: Am J Pathol
– volume: 40
  start-page: 1276
  year: 2007
  end-page: 83
  article-title: Comparison of the roles of IL‐1, IL‐6, and TNFalpha in cell culture and murine models of aseptic loosening
  publication-title: Bone
– volume: 405
  start-page: 158
  year: 2002
  end-page: 63
  article-title: Ceramic‐on‐ceramic bearings in total hip arthroplasty
  publication-title: Clin Orthop Relat Res
– volume: 427
  start-page: 138
  year: 2004
  end-page: 47
  article-title: Osteolysis: medical and surgical approaches
  publication-title: Clin Orthop Relat Res
– volume: 54
  start-page: 127
  year: 2005
  end-page: 31
  article-title: TNF‐alpha and pathologic bone resorption
  publication-title: Keio J Med
– volume: 20
  start-page: 757
  year: 2006
  end-page: 90
  article-title: Problems encountered during anti‐tumour necrosis factor therapy
  publication-title: Best Pract Res Clin Rheumatol
– volume: 5
  start-page: 380
  year: 1998
  end-page: 7
  article-title: Time‐dependent maturation of cationic liposome‐DNA complex for serum resistance
  publication-title: Gene Ther
– volume: 117
  start-page: 94
  year: 2008
  end-page: 104
  article-title: Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs
  publication-title: Pharmacol Ther
– volume: 82
  start-page: 944
  year: 2000
  end-page: 7
  article-title: The Trent regional arthroplasty study. Experiences with a hip register
  publication-title: J Bone Joint Surg Br
– volume: 295
  start-page: 2275
  year: 2006
  end-page: 85
  article-title: Anti‐TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta‐analysis of rare harmful effects in randomized controlled trials
  publication-title: JAMA
– volume: 391
  start-page: 806
  year: 1998
  end-page: 11
  article-title: Potent and specific genetic interference by double‐stranded RNA in Caenorhabditis elegans
  publication-title: Nature
– volume: 89
  start-page: 2499
  year: 2007
  end-page: 503
  article-title: Alumina‐debris‐induced osteolysis in contemporary alumina‐on‐alumina total hip arthroplasty. A case report
  publication-title: J Bone Joint Surg Am
– volume: 169
  start-page: 5754
  year: 2002
  end-page: 60
  article-title: Small interfering RNA‐mediated gene silencing in T lymphocytes
  publication-title: J Immunol
– volume: 20
  start-page: 174
  year: 2002
  end-page: 81
  article-title: Tumor necrosis factor‐alpha mediates polymethylmethacrylate particle‐induced NF‐kappaB activation in osteoclast precursor cells
  publication-title: J Orthop Res
– volume: 2
  start-page: 736
  year: 2003
  end-page: 46
  article-title: Anti‐TNF‐alpha therapies: the next generation
  publication-title: Nat Rev Drug Discov
– volume: 30
  start-page: 1756
  year: 2009
  end-page: 62
  article-title: Inhibition of titanium particle‐induced osteoclastogenesis through inactivation of NFATc1 by VIVIT peptide
  publication-title: Biomaterials
– ident: e_1_2_8_21_2
  doi: 10.1261/rna5160904
– volume: 14
  start-page: 643
  year: 1996
  ident: e_1_2_8_8_2
  article-title: Tumor necrosis factor‐alpha (TNF‐alpha) in loosening of total hip replacement (THR)
  publication-title: Clin Exp Rheumatol
  contributor:
    fullname: Xu JW
– ident: e_1_2_8_10_2
  doi: 10.1097/00003086-200212000-00019
– ident: e_1_2_8_12_2
  doi: 10.1016/j.berh.2006.06.002
– ident: e_1_2_8_15_2
  doi: 10.1016/j.bone.2006.12.053
– ident: e_1_2_8_24_2
  doi: 10.1016/S0002-9440(10)63016-7
– ident: e_1_2_8_5_2
  doi: 10.1038/sj.gt.3302192
– ident: e_1_2_8_19_2
  doi: 10.4049/jimmunol.180.6.4292
– ident: e_1_2_8_22_2
  doi: 10.4049/jimmunol.169.10.5754
– ident: e_1_2_8_20_2
  doi: 10.1001/jama.295.19.2275
– ident: e_1_2_8_23_2
  doi: 10.1038/sj.gt.3300596
– ident: e_1_2_8_16_2
  doi: 10.1016/j.biomaterials.2008.12.018
– ident: e_1_2_8_17_2
  doi: 10.1016/j.biomaterials.2006.04.004
– ident: e_1_2_8_14_2
  doi: 10.1016/j.pharmthera.2007.08.004
– volume: 89
  start-page: 2499
  year: 2007
  ident: e_1_2_8_3_2
  article-title: Alumina‐debris‐induced osteolysis in contemporary alumina‐on‐alumina total hip arthroplasty. A case report
  publication-title: J Bone Joint Surg Am
  doi: 10.2106/JBJS.G.00130
  contributor:
    fullname: Nam KW
– ident: e_1_2_8_7_2
  doi: 10.1111/j.1525-1594.2009.00736.x
– ident: e_1_2_8_13_2
  doi: 10.1038/35888
– ident: e_1_2_8_9_2
  doi: 10.1016/S0736-0266(01)00088-2
– ident: e_1_2_8_11_2
  doi: 10.2302/kjm.54.127
– ident: e_1_2_8_6_2
  doi: 10.1097/01.blo.0000142288.66246.4d
– ident: e_1_2_8_2_2
  doi: 10.1302/0301-620X.82B7.10762
– ident: e_1_2_8_18_2
  doi: 10.1038/nrd1175
– ident: e_1_2_8_4_2
  doi: 10.1002/jbm.b.30120
SSID ssj0007406
Score 2.0792432
Snippet Aseptic joint loosening is a key factor that reduces the life span of arthroplasty. There are currently few effective treatments for joint loosening except...
Abstract Aseptic joint loosening is a key factor that reduces the life span of arthroplasty. There are currently few effective treatments for joint loosening...
SourceID proquest
crossref
pubmed
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 706
SubjectTerms Animals
Arthroplasty
Cell Line
Down-Regulation
Hip arthroplasty
Inflammation - genetics
Inflammation - immunology
Macrophages - immunology
Macrophages - metabolism
Mice
Periprosthetic osteolysis
RNA Interference
RNA, Messenger - genetics
RNA, Small Interfering - genetics
RNA, Small Interfering - therapeutic use
Transfection
Tumor Necrosis Factor-alpha - genetics
Tumor Necrosis Factor-alpha - immunology
Wear particle
Title Down-Regulation of TNF-Alpha by Small Interfering RNA Inhibits Particle-Induced Inflammation In Vitro
URI https://api.istex.fr/ark:/67375/WNG-9GGBZJBR-B/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1525-1594.2010.01175.x
https://www.ncbi.nlm.nih.gov/pubmed/21501190
https://search.proquest.com/docview/876783773
https://search.proquest.com/docview/888095695
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELfQJiFe-P7I-JAfEG-pmvgreWw32mnSCgobVLxYdmxrVUeL2lTa9rQ_gb-Rv4S7JC0UTQgh3uI4TuLzne_OvvuZkNfWC8yRsTFzSYi5kQHmQe_jjHnp09QxYzB3-HgkD0_50ViM2_gnzIVp8CE2C24oGfV8jQJu7HJbyEUqYlDHvI3QQtTJDtqTCVMY3XVQ_ESSUrw-ZhPx1GIh-Xg7qOfGF21pql0k-sVNZui2VVurpcE9Ml13qIlGmXZWle2UV79hPf6fHt8nd1vrlfYadntAbvnZQ3L7uN2ff0SmB-DUf7_-VjQn3MOY03mgJ6MB3OthVi-1l_TDF3N-TuulyFADIdJi1IPy2cROqiV93zIzNMFzRUrvoC4A4zZJllCgHyfVYv6YnA7enuwfxu1xDnEpMMXB2LTrU5VL17WKKYu2mvfBS-FsaTPLA9iaygCXdF2SZyGx0iB6HuM-cz6T7AnZmc1n_hmhQnjneCmlw0TawPMQmDC5VZkx0hoVkWQ9dPprg9qhf_F2gIoaqaiRirqmor6IyJt6jDcNzGKKUW9Q92k01Plw2P981C90PyJ0zQQaZBE3WMzMz1dLDZpFgcOv2B8egfkSXNJcRORpwz-b74HxhQB83YjImgv--s91712BV3v_2vA5udMslWMU8guyUy1W_iXYWpV9VUvRD15QHJc
link.rule.ids 315,783,787,1378,27936,27937,46306,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQrgRceD_C0wfELVUbP5IcW5a2LNuAQhcqLpYd26Jqt111U2nhxE_gN_JLmEnSQtEKIcQtjuMkHs94xvbMN4Q8M05gjIwJme34kGvpYR50LkyYky6KLNMaY4dHmRwe88OJmDTpgDAWpsaH2G64oWRU8zUKOG5I70q5iEQI-pg3LloIO9kCg3IfpJ9hHoeD_CeWVMyrRJuIqBYKySe7bj0XvmlHV-0j2c8vMkR37dpKMfWvk_mmS7U_yqy1Lk2r-PIb2uN_6vMNcq0xYGm35rib5JJb3CKXR80R_W0yO4B1_fev3_I6yT0MO116Os76cK-Lgb3UfKbvTvR8TqvdSF9hIdI860L509RMyzP6tuFnaIKpRQpnoc4D79ZxllCg76flanmHHPdfjl8MwyajQ1gIjHLQJmq7KE6lbZuYxQbNNee8k8KawiSGezA3Yw2M0radNPEdIzUC6DHuEusSye6SvcVy4e4TKoSzlhdSWoyl9Tz1ngmdmjjRWhodB6SzGTt1WgN3qF8WPEBFhVRUSEVVUVGdB-R5NcjbBno1Q8c3qPuQDVQ6GPQ-HvZy1QsI3XCBAnHEMxa9cMv1mQLlEsOaP2Z_eASmTFiVpiIg92oG2n4P7C_E4GsHRFZs8Nd_rrpvcrx68K8Nn5Irw_HoSB29yl4_JFfrnXN0Sn5E9srV2j0G06s0TyqR-gEafiCv
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwFLbQJk28cIeFqx8Qb6naxJfksWW0Y7AwhQ0qXiw7tkXV0U5dKg2e-An8Rn4J5zhpoWhCCPEWx3ESH59jf7bP-UzIU-M4xsiYOLU9HzMtPPSDzsVZ6oRLEptqjbHDh4XYP2EHYz5u_Z8wFqbhh1gvuKFlhP4aDfzM-k0j5wmPYThmrYcWsk52AE9uMwFAGAFS-ZNKSrJwziYSqsVcsPGmV8-lb9oYqrZR6heX4dBNWBvGpeF1Ml3VqHFHmXaWtelUX34je_w_Vb5BrrXwlfYbfbtJrrjZLbJz2G7Q3ybTPZjVf__6rWyOuIdGp3NPj4sh3OtjWC81n-nbT_r0lIa1SB-YEGlZ9CH9cWIm9Tk9arUZiuDBIpWzkOdBc5soS0jQd5N6Mb9DToYvjp_vx-15DnHFMcZBm6TrEpkL2zUylQbBmnPeCW5NZTLDPIBNqUFNuraXZ75nhEb6vJS5zLpMpHfJ1mw-c7uEcu6sZZUQFiNpPcu9T7nOjcy0FkbLiPRWTafOGtoO9ct0B6SoUIoKpaiCFNVFRJ6FNl4X0Ispur1B3vtipPLRaPDhYFCqQUToSgkUGCPusOiZmy_PFQwtEmb8Mv3DI9Bhwpw05xG51-jP-nuAvpCBrxsREbTgr_9c9d-UeHX_Xws-ITtHe0P1-mXx6gG52iybo0fyQ7JVL5buEeCu2jwOBvUDkxIfXg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Down-regulation+of+TNF-alpha+by+small+interfering+RNA+inhibits+particle-induced+inflammation+in+vitro&rft.jtitle=Artificial+organs&rft.au=Qin%2C+Chu-qiang&rft.au=Ding%2C+Yue&rft.au=Huang%2C+Dong-sheng&rft.au=Xu%2C+Jie&rft.date=2011-07-01&rft.eissn=1525-1594&rft.volume=35&rft.issue=7&rft.spage=706&rft_id=info:doi/10.1111%2Fj.1525-1594.2010.01175.x&rft_id=info%3Apmid%2F21501190&rft.externalDocID=21501190
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0160-564X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0160-564X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0160-564X&client=summon